Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study.

Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van den Hoogen HJ, van de Lisdonk EH, Metsemakers JF, van Weel C.

Ann Fam Med. 2009 Sep-Oct;7(5):422-30. doi: 10.1370/afm.997.

2.

How to improve opportunistic screening by using EMRs and other data. The prevalence of undetected diabetes mellitus in target population in Croatia.

Vrca Botica M, Carkaxhiu L, Kern J, Pavlić Renar I, Botica I, Zelić I, Iliev D, Vrca A.

Public Health. 2017 Apr;145:30-38. doi: 10.1016/j.puhe.2016.12.008. Epub 2017 Jan 19.

PMID:
28359387
3.

Vascular outcomes in patients with screen-detected or clinically diagnosed type 2 diabetes: Diabscreen study follow-up.

Klein Woolthuis EP, de Grauw WJ, van Keeken SM, Akkermans RP, van de Lisdonk EH, Metsemakers JF, van Weel C.

Ann Fam Med. 2013 Jan-Feb;11(1):20-7. doi: 10.1370/afm.1460.

4.

Screening for type 2 diabetes in primary care using a stepwise protocol: the Diabscreen study.

Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van den Hoogen HJ, van de Lisdonk EH, Metsemakers JF, van Weel C.

Prim Care Diabetes. 2007 Dec;1(4):199-202. doi: 10.1016/j.pcd.2007.09.002. Epub 2007 Oct 30.

PMID:
18632046
5.

Low yield of population-based screening for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study.

Janssen PG, Gorter KJ, Stolk RP, Rutten GE.

Fam Pract. 2007 Dec;24(6):555-61. Epub 2007 Oct 25.

PMID:
17962235
6.

Irish diabetes detection programme in general practice.

Smith SM, Holohan J, McAuliffe A, Firth RG.

Diabet Med. 2003 Sep;20(9):717-22.

PMID:
12925050
7.

Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.

Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, Tognoni G, Valentini M, Nicolucci A.

Diabetes Care. 2005 May;28(5):1187-94.

PMID:
15855587
8.

Identifying people at risk for undiagnosed type 2 diabetes using the GP's electronic medical record.

Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van den Hoogen HJ, van de Lisdonk EH, Metsemakers JF, van Weel C.

Fam Pract. 2007 Jun;24(3):230-6. Epub 2007 May 16.

PMID:
17510087
9.

Do characteristics of practices and general practitioners influence the yield of diabetes screening in primary care? The ADDITION Netherlands study.

Janssen PG, Gorter KJ, Stolk RP, Rutten GE.

Scand J Prim Health Care. 2008;26(3):160-5. doi: 10.1080/08037050802117924.

10.

A type 2 diabetes screening program by general practioners in a Belgian at risk population.

Buysschaert M, Vandenbroucke C, Barsoum S.

Diabetes Metab. 2001 Apr;27(2 Pt 1):109-14.

PMID:
11353875
11.

Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).

Hauner H, Hanisch J, Bramlage P, Steinhagen-Thiessen E, Schunkert H, Jöckel KH, Wasem J, Moebus S.

Exp Clin Endocrinol Diabetes. 2008 Jan;116(1):18-25. Epub 2007 Oct 9.

PMID:
17926235
12.

Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms.

Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K.

Diabetologia. 2004 Sep;47(9):1566-73. Epub 2004 Sep 8.

PMID:
15365615
13.

The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.

Neira CP, Hartig M, Cowan PA, Velasquez-Mieyer PA.

J Am Acad Nurse Pract. 2009 Mar;21(3):173-8. doi: 10.1111/j.1745-7599.2008.00380.x.

PMID:
19302694
14.

A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome.

Li J, Bergmann A, Reimann M, Bornstein SR, Schwarz PE.

Horm Metab Res. 2009 Feb;41(2):98-103. doi: 10.1055/s-0028-1087191. Epub 2008 Oct 29.

PMID:
18975253
15.

Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study.

Spijkerman AM, Henry RM, Dekker JM, Nijpels G, Kostense PJ, Kors JA, Ruwaard D, Stehouwer CD, Bouter LM, Heine RJ.

J Intern Med. 2004 Nov;256(5):429-36.

16.

Diabetes screening in primary care: the PRE.DI.CO. study.

Bonaccorsi G, Guarducci S, Ruffoli E, Lorini C.

Ann Ig. 2012 Nov-Dec;24(6):527-34.

PMID:
23234190
17.

A simple pragmatic system for detecting new cases of type 2 diabetes and impaired fasting glycaemia in primary care.

Greaves CJ, Stead JW, Hattersley AT, Ewings P, Brown P, Evans PH.

Fam Pract. 2004 Feb;21(1):57-62.

PMID:
14760046
18.

Reconsidering the age thresholds for type II diabetes screening in the U.S.

Chung S, Azar KM, Baek M, Lauderdale DS, Palaniappan LP.

Am J Prev Med. 2014 Oct;47(4):375-81. doi: 10.1016/j.amepre.2014.05.012. Epub 2014 Aug 15.

19.

Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy.

Costa B, Barrio F, Piñol JL, Cabré JJ, Mundet X, Sagarra R, Salas-Salvadó J, Solà-Morales O; DE-PLAN-CAT/PREDICE Research Group.

BMC Med. 2013 Feb 21;11:45. doi: 10.1186/1741-7015-11-45.

20.

Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000.

Rathmann W, Martin S, Haastert B, Icks A, Holle R, Löwel H, Giani G; KORA Study Group.

Arch Intern Med. 2005 Feb 28;165(4):436-41.

PMID:
15738374

Supplemental Content

Support Center